Marina Biotech, Inc. Stock OTC Bulletin Board
Equities
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Sales 2021 | - | Sales 2022 | - | Capitalization | 2.59M 3.56M |
---|---|---|---|---|---|
Net income 2021 | -6M -8.23M | Net income 2022 | -2M -2.74M | EV / Sales 2021 | - |
Net Debt 2021 | 6.59M 9.04M | Net Debt 2022 | 8.55M 11.74M | EV / Sales 2022 | - |
P/E ratio 2021 |
-0.11
x | P/E ratio 2022 |
-0.69
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 88.26% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Operating Officer | 43 | 20-07-06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Charles L. Rice
BRD | Director/Board Member | 59 | 20-07-09 |
Chief Operating Officer | 43 | 20-07-06 |
1st Jan change | Capi. | |
---|---|---|
-1.17% | 104B | |
+2.87% | 97.47B | |
+3.76% | 22.25B | |
-14.77% | 21.68B | |
-9.00% | 18.2B | |
-39.98% | 17.02B | |
-13.21% | 16.36B | |
+8.55% | 14.39B | |
+35.75% | 12.37B |